Episurf Medical AB (publ)

LSE:0QUT Stock Report

Market Cap: SEK 88.7m

Episurf Medical Management

Management criteria checks 4/4

Episurf Medical's CEO is Pal Ryfors, appointed in Jun 2017, has a tenure of 7.58 years. total yearly compensation is SEK4.50M, comprised of 84.4% salary and 15.6% bonuses, including company stock and options. directly owns 2.69% of the company’s shares, worth SEK2.39M. The average tenure of the management team and the board of directors is 6.6 years and 8.7 years respectively.

Key information

Pal Ryfors

Chief executive officer

SEK 4.5m

Total compensation

CEO salary percentage84.4%
CEO tenure7.6yrs
CEO ownership2.7%
Management average tenure6.6yrs
Board average tenure8.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Pal Ryfors's remuneration changed compared to Episurf Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 80m

Jun 30 2024n/an/a

-SEK 85m

Mar 31 2024n/an/a

-SEK 92m

Dec 31 2023SEK 5mSEK 4m

-SEK 95m

Sep 30 2023n/an/a

-SEK 97m

Jun 30 2023n/an/a

-SEK 94m

Mar 31 2023n/an/a

-SEK 84m

Dec 31 2022SEK 5mSEK 4m

-SEK 77m

Sep 30 2022n/an/a

-SEK 72m

Jun 30 2022n/an/a

-SEK 71m

Mar 31 2022n/an/a

-SEK 69m

Dec 31 2021SEK 4mSEK 3m

-SEK 69m

Sep 30 2021n/an/a

-SEK 67m

Jun 30 2021n/an/a

-SEK 66m

Mar 31 2021n/an/a

-SEK 63m

Dec 31 2020SEK 4mSEK 3m

-SEK 64m

Sep 30 2020n/an/a

-SEK 66m

Jun 30 2020n/an/a

-SEK 69m

Mar 31 2020n/an/a

-SEK 73m

Dec 31 2019SEK 2mSEK 2m

-SEK 70m

Sep 30 2019n/an/a

-SEK 66m

Jun 30 2019n/an/a

-SEK 62m

Mar 31 2019n/an/a

-SEK 59m

Dec 31 2018SEK 2mSEK 2m

-SEK 58m

Compensation vs Market: Pal's total compensation ($USD403.58K) is about average for companies of similar size in the UK market ($USD346.86K).

Compensation vs Earnings: Pal's compensation has been consistent with company performance over the past year.

CEO

Pal Ryfors (41 yo)

7.6yrs

Tenure

SEK 4,500,000

Compensation

Mr. Pal Ryfors is Independent Director of Vivesto AB since May 2022. He serves as Chief Executive Officer of Episurf Medical AB (publ) since June 2, 2017 and served as its Acting Sales Director since 2021....

Leadership Team

NamePositionTenureCompensationOwnership
Pal Ryfors
Chief Executive Officer7.6yrsSEK 4.50m2.69%
SEK 2.4m
Veronica Wallin
Chief Financial Officer7.6yrsno data0.049%
SEK 43.9k
Katarina Flodström
Chief Operating Officer5.6yrsno data0.016%
SEK 14.0k
Fredrik Zetterberg
Marketing Director8yrsno data0.0041%
SEK 3.6k
Ylva Bonde
Head of QA & RAless than a yearno datano data
Patrick Jamnik
President of Episurf Medical Inc3.4yrsno data0.14%
SEK 121.4k

6.6yrs

Average Tenure

43yo

Average Age

Experienced Management: 0QUT's management team is seasoned and experienced (6.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ulf Grunander
Independent Chairman of the Board3.7yrsSEK 400.00k0.30%
SEK 269.1k
Annette Rampe
Independent Director3.7yrsSEK 200.00k0.037%
SEK 32.7k
Laura Shunk
Independent Director8yrsSEK 200.00k0.12%
SEK 109.0k
Leif Ryd
Member of Clinical Advisory Board & Director16yrsSEK 800.00k0.090%
SEK 79.5k
Tim Spalding
Member of Clinical Advisory Board9.2yrsno datano data
Johannes Holz
Member of Clinical Advisory Board9.2yrsno datano data
Mats Brittberg
Member of Clinical Advisory Board9.2yrsno datano data
Karl Eriksson
Member of Clinical Advisory Board9.2yrsno datano data
Christian Krueger
Independent Director8.7yrsSEK 200.00k0.046%
SEK 40.9k
Adam Mitchell
Member of Clinical Advisory Board7.9yrsno datano data
C. van Dijk
Member of Clinical Advisory Board5.8yrsno datano data
Joao Mendes
Member of Clinical Advisory Boardno datano datano data

8.7yrs

Average Tenure

67yo

Average Age

Experienced Board: 0QUT's board of directors are considered experienced (8.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 22:40
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Episurf Medical AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yilmaz MahshidPareto Securities
Anders HedlundRedeye
John WestborgRedeye